tiprankstipranks
Trending News
More News >
Revvity, Inc. (RVTY)
NYSE:RVTY
US Market

Revvity (RVTY) Earnings Dates, Call Summary & Reports

Compare
554 Followers

Earnings Data

Report Date
May 04, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
1.04
Last Year’s EPS
1.01
Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 02, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call highlighted clear operational resilience—EPS and cash flow beats, strong diagnostics and software momentum, major share repurchases, and strategic AI/software initiatives—offset by persistent end-market softness, China diagnostic weakness, margin pressure and a conservative 2026 growth outlook. Achievements (guidance beat, FCF strength, software traction, ACD acquisition, Signals Synthetica launch) are balanced by notable challenges (modest organic growth guidance, China DRG impacts, near-term margin headwinds, rising below-the-line costs), resulting in a cautious but constructive tone.
Company Guidance
Revvity guided 2026 with 2–3% organic growth (Q1 in line with the full‑year), an approximate 1% FX tailwind for the year (≈3% FX benefit in Q1), and ~75 bps contribution (~$20M) from the ACD acquisition, implying total revenue of $2.96–$2.99 billion; adjusted operating margin is targeted at 28% (cost‑efficiency programs to be completed by end of Q2, with margins stepping up in Q2 and the back half after a Q1 trough of ~23%), and full‑year adjusted EPS is guided to $5.35–$5.45 (high‑single‑digit EPS growth) with Q1 EPS expected to be ~19% of the full year. Management assumes diluted shares of ~112 million, adjusted net interest & other of ~$95M (up from $84M), an 18% adjusted tax rate (vs. 14.5% in 2025), and expects free‑cash‑flow conversion of ~85%+ (2025 conversion was 87% with $515M FCF; Q4 FCF was $162M). The extra operating week in Q1 provides ~100 bps of organic‑growth tailwind (~20 bps FY) but is roughly a $0.06 EPS headwind.
Quarterly and Full-Year Revenue Performance
Q4 revenue of $772 million with 4% organic growth; full-year revenue of $2.86 billion with 3% organic growth, in line with prior guidance despite headwinds.
Earnings and Margin Outperformance
Q4 adjusted EPS $1.70 (beat midpoint by $0.11 and high end by $0.06); full-year adjusted EPS $5.06, above the high end of initial guidance and up 3% year-over-year. Q4 adjusted operating margin was 29.7%.
Strong Free Cash Flow and Balance Sheet
Q4 free cash flow of $162 million and full-year FCF of $515 million with 84% and 87% conversion of adjusted net income respectively; net debt/adjusted EBITDA of 2.7x with 100% fixed-rate debt (weighted avg interest 2.6%).
Aggressive Share Repurchases
Repurchased over $800 million of shares in 2025 (8.5 million shares), bringing total repurchases since 2023 to >$1.5 billion (~15 million shares, ~12% of shares outstanding at the time), reducing diluted share count and supporting EPS.
Diagnostics Momentum
Diagnostics segment organic growth +7% in Q4 (reported +10%); full-year diagnostics organic growth +4%; reproductive health grew mid-single digits and newborn screening grew mid-single in Q4 and high-single for the year.
Software & Signals Strength
Signals software grew high-teens organically for the full year; SaaS ARR grew nearly 40% YoY with SaaS representing ~35% of the business; net retention >110% and double-digit APV growth.
Strategic M&A and Product Innovation
Closed acquisition of ACD Labs in mid-January expected to add >$20 million (~75 bps to revenue growth) in 2026; launched Signals Synthetica AI platform and announced collaboration with Lilly TuneLab to accelerate adoption.
2026 Financial Framework
Reiterated 2026 guidance: organic growth 2%–3%, total revenue $2.96–$2.99 billion (includes ~1% FX tailwind and ACD contribution), adjusted operating margin target 28%, and adjusted EPS guidance $5.35–$5.45 (high single-digit EPS growth).

Revvity (RVTY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RVTY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 04, 2026
2026 (Q1)
1.04 / -
1.01
Feb 02, 2026
2025 (Q4)
1.57 / 1.70
1.4219.72% (+0.28)
Oct 27, 2025
2025 (Q3)
1.14 / 1.18
1.28-7.81% (-0.10)
Jun 29, 2025
2025 (Q2)
1.15 / 1.18
1.22-3.28% (-0.04)
Apr 28, 2025
2025 (Q1)
0.95 / 1.01
0.983.06% (+0.03)
Jan 31, 2025
2024 (Q4)
1.37 / 1.42
1.2513.60% (+0.17)
Nov 04, 2024
2024 (Q3)
1.13 / 1.28
1.188.47% (+0.10)
Jul 29, 2024
2024 (Q2)
1.12 / 1.22
1.210.83% (+0.01)
Apr 29, 2024
2024 (Q1)
0.94 / 0.98
1.01-2.97% (-0.03)
Feb 01, 2024
2023 (Q4)
1.17 / 1.25
1.7-26.47% (-0.45)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

RVTY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 02, 2026
$108.80$107.09-1.57%
Oct 27, 2025
$98.83$97.10-1.75%
Apr 28, 2025
$94.09$94.86+0.82%
Jan 31, 2025
$126.48$125.77-0.56%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Revvity, Inc. (RVTY) report earnings?
Revvity, Inc. (RVTY) is schdueled to report earning on May 04, 2026, After Close (Confirmed).
    What is Revvity, Inc. (RVTY) earnings time?
    Revvity, Inc. (RVTY) earnings time is at May 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RVTY EPS forecast?
          RVTY EPS forecast for the fiscal quarter 2026 (Q1) is 1.04.

            Revvity (RVTY) Earnings News

            Revvity (NYSE:RVTY) Tanks on Q3 Miss
            Premium
            Market News
            Revvity (NYSE:RVTY) Tanks on Q3 Miss
            2y ago